Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

480 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk Factors for the Development of Retinopathy in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Experience.
White NH, Pan Q, Knowler WC, Schroeder EB, Dabelea D, Chew EY, Blodi B, Goldberg RB, Pi-Sunyer X, Darwin C, Schlögl M, Nathan DM; Diabetes Prevention Program Outcome Study (DPPOS) Research Group. White NH, et al. Among authors: nathan dm. Diabetes Care. 2022 Nov 1;45(11):2653-2661. doi: 10.2337/dc22-0860. Diabetes Care. 2022. PMID: 36098658 Free PMC article.
Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group; Lachin JM, Genuth S, Cleary P, Davis MD, Nathan DM. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group, et al. Among authors: nathan dm. N Engl J Med. 2000 Feb 10;342(6):381-9. doi: 10.1056/NEJM200002103420603. N Engl J Med. 2000. PMID: 10666428 Free PMC article. Clinical Trial.
Screening for diabetes: can we afford not to screen?
Nathan DM, Herman WH. Nathan DM, et al. Ann Intern Med. 2004 May 4;140(9):756-8. doi: 10.7326/0003-4819-140-9-200405040-00017. Ann Intern Med. 2004. PMID: 15126261 No abstract available.
Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program.
Knowler WC, Hamman RF, Edelstein SL, Barrett-Connor E, Ehrmann DA, Walker EA, Fowler SE, Nathan DM, Kahn SE; Diabetes Prevention Program Research Group. Knowler WC, et al. Among authors: nathan dm. Diabetes. 2005 Apr;54(4):1150-6. doi: 10.2337/diabetes.54.4.1150. Diabetes. 2005. PMID: 15793255 Free PMC article. Clinical Trial.
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Nathan DM, et al. N Engl J Med. 2005 Dec 22;353(25):2643-53. doi: 10.1056/NEJMoa052187. N Engl J Med. 2005. PMID: 16371630 Free PMC article. Clinical Trial.
TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program.
Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PI, Shuldiner AR, Knowler WC, Nathan DM, Altshuler D; Diabetes Prevention Program Research Group. Florez JC, et al. Among authors: nathan dm. N Engl J Med. 2006 Jul 20;355(3):241-50. doi: 10.1056/NEJMoa062418. N Engl J Med. 2006. PMID: 16855264 Free PMC article.
480 results